Merck Scores US FDA Approval For Subcutaneous Keytruda Qlex

 
• By Alaric DeArment
  
Keytruda Qlex was approved nine months after the FDA cleared Opdivo Qvantig (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip